查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829720

2025年全球胰島素輸送裝置市場報告

Insulin Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，胰島素給藥裝置市場規模強勁成長，從2024年的177.1億美元增加至2025年的190.7億美元，複合年成長率為7.7%。預測期間的成長可歸因於胰島素給藥裝置便捷易用的特性、優惠的報銷政策、肥胖盛行率的上升、人口老化加劇以及胰島素幫浦普及率的提高。

預計未來幾年胰島素給藥裝置市場規模將強勁成長，2029年將達到259.8億美元，複合年成長率為8.0%。預測期內的成長可歸因於糖尿病患者數量的成長、糖尿病治療醫療支出的增加、持續血糖監測系統的興起、患者對自動化胰島素給藥裝置益處的認知不斷提高以及人們對醫療保健的日益重視。預測期間的主要趨勢包括胰島素給藥裝置的技術進步、胰島素給藥裝置與數位技術的整合、人工胰臟系統的發展、胰島素給藥技術的進步以及仿生技術的進步。

胰島素輸送裝置是專為糖尿病患者注射胰島素而設計的醫療器材。對於無法自然分泌足夠胰島素的患者，這類裝置對於血糖值的控制至關重要。它們可以有效控制血糖值，並為胰島素注射提供靈活性和便利性。

胰島素給藥裝置的主要類型包括胰島素注射器、胰島素噴射注射器、筆式針頭、可重複使用胰島素筆、拋棄式胰島素筆、胰島素幫浦、體外幫浦、繫留幫浦和貼片幫浦。胰島素注射器專為皮下注射胰島素而設計，其特點是針頭細而短，並帶有清晰的劑量指示器，以確保激素給藥的準確性。這些裝置可用於治療第1型和第2型糖尿病，可透過多種管道購買，包括醫院藥局、零售藥局、線上銷售以及糖尿病診所和中心。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供胰島素注射裝置市場統計數據，包括全球市場規模、區域佔有率、胰島素注射裝置市場佔有率競爭對手、詳細的胰島素注射裝置細分市場、市場趨勢和商機，以及您在胰島素注射裝置行業取得成功所需的數據。本胰島素注射裝置市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.0%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自新加坡和加拿大等主要地區的微流體晶片和藍牙劑量追蹤器徵收關稅直接影響美國，從而導致糖尿病管理方案減少，智慧胰島素技術成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響可能會更加廣泛。

糖尿病盛行率的不斷上升預計將在未來幾年推動胰島素輸送裝置市場的成長。糖尿病是一種慢性疾病，其特徵是由於胰臟分泌胰島素不足或身體無法有效利用胰島素而導致血糖值升高。糖尿病患者人數的增加主要是由於久坐不動的生活方式、不良飲食習慣和全球肥胖率上升等因素。胰島素輸送裝置對於管理糖尿病至關重要，因為控制和方便地注射胰島素可以有效控制血糖值、預防併發症並促進整體健康。例如，根據美國疾病管制與預防中心的數據，截至 2022 年 12 月，到 2060 年，美國20 歲以下 2 型糖尿病患者人數可能增加近 700%，達到 22 萬人。此外，同期年輕人中第 1 型糖尿病的診斷率可能增加 65%。糖尿病盛行率的不斷上升刺激了胰島素給藥裝置市場的擴張。

胰島素輸送設備市場的主要企業正致力於開發創新產品，例如提供持續或可客製化胰島素輸送的胰島素幫浦。胰島素幫浦是可程式設計的醫療設備透過皮下導管持續或按需輸送胰島素。例如，2023年5月，美國醫療科技公司Beta Bionics的iLet ACE幫浦和iLet給藥決策軟體獲得了美國食品藥物管理局）的核准。 iLet仿生胰臟系統專為6歲及以上第1型糖尿病患者設計，將兩種設備與相容的FDA核准的整合式連續血糖監測儀（iCGM）整合在一起。該系統採用自適應閉合迴路演算法驅動的自動胰島素給藥（AID）系統進行操作，僅需用戶體重即可進行設置，無需額外的胰島素給藥參數。與傳統的泵療法不同，該系統無需手動設定調整，易於啟動和管理。此外，iLet設備還引進了用餐提示功能。它透過將餐點分為小餐、中餐和大餐來簡化用餐時的胰島素劑量，並且演算法會隨著時間的推移學習並適應個人的胰島素需求。

2023年9月，美國醫療保健公司雅培（Abbott）收購了Bigfoot Biomedical，收購金額未揭露。此次收購將增強雅培在糖尿病照護領域的地位，擴大其享有盛譽的FreeStyle Libre動態血糖監測技術產品組合。此次收購符合雅培推動互聯解決方案，實現個人化和精細化糖尿病管理的策略。 Bigfoot Biomedical是一家總部位於美國的胰島素輸送設備製造商。

胰島素給藥裝置市場涵蓋胰島素輸注器、胰島素儲液器、胰島素幫浦配件和胰島素筆芯的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球胰島素輸送裝置：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球胰島素輸送裝置市場：成長率分析
  • 全球胰島素輸送裝置市場表現：規模與成長，2019-2024
  • 全球胰島素注射裝置市場預測：規模與成長，2024-2029年，2034年
  • 全球胰島素輸送裝置：總目標市場（TAM）

第6章 市場細分

  • 全球胰島素注射裝置市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 胰島素注射器
  • 胰島素噴射注射器
  • 筆針
  • 可重複使用的胰島素筆
  • 拋棄式胰島素筆
  • 胰島素幫浦
  • 外部或繫留泵
  • 貼片幫浦
  • 全球胰島素輸送裝置市場（依疾病適應症、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 類型 1
  • 類型 2
  • 全球胰島素給藥裝置市場（按分銷管道）：2019-2024 年、2024-2029 年、2034 年實際及預測
  • 醫院藥房
  • 零售藥局
  • 網上銷售
  • 糖尿病診所或中心
  • 全球胰島素注射裝置市場：按胰島素注射器類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 標準胰島素注射器
  • 固定或可調式針長胰島素注射器
  • 全球胰島素注射裝置市場：按胰島素噴射注射器類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 無針頭胰島素注射器
  • 高壓胰島素噴射注射器
  • 全球胰島素注射裝置市場：按筆針細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 短筆針
  • 長筆針
  • 全球胰島素輸送裝置市場：可重複使用胰島素筆細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 可重複使用的筆，附有可更換的墨盒
  • 可再填充胰島素筆
  • 全球胰島素輸送裝置市場：細分拋棄式胰島素筆（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 一次性使用的拋棄式胰島素筆
  • 一次性預填充胰島素筆
  • 全球胰島素輸送裝置市場：按胰島素幫浦類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 傳統胰島素泵
  • 智慧胰島素泵
  • 全球胰島素輸送裝置市場：按類型細分：外部或系留幫浦、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 傳統外部胰島素泵
  • 無線繫繩幫浦
  • 全球胰島素輸送裝置市場：貼片幫浦細分（按類型）、績效及預測，2019-2024、2024-2029、2034
  • 貼片式胰島素幫浦
  • 整合貼片幫浦

第7章 區域和國家分析

  • 全球胰島素注射裝置市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球胰島素注射裝置市場：國家、績效及預測，2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 胰島素輸送裝置市場：競爭格局
  • 胰島素輸送裝置市場：公司簡介
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novo Nordisk A/S
  • Becton, Dickinson and Company
  • EOFlow Co. Ltd.
  • Insulet Corporation
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • Xeris Pharmaceuticals Inc.
  • Beta Bionics Inc.
  • Zealand Pharma AS
  • Bigfoot Biomedical Inc.
  • Emperra GmbH
  • Animas Corporation
  • Debiotech SA
  • CeQur Corporation
  • Aerami Therapeutics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年胰島素注射裝置市場：提供新機會的國家
  • 2029年胰島素輸送裝置市場：細分市場將帶來新機會
  • 胰島素注射裝置市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30483u

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.07 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, increasing adoption of insulin pumps.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing prevalence of diabetic population, increasing healthcare expenditure on diabetes care, rise of continuous glucose monitoring systems, growing awareness among patients about benefits of automated insulin delivery devices, rising focus on healthcare. Major trends in the forecast period include technological advancements in insulin delivery devices, integration of digital technology with insulin delivery devices, development of artificial pancreas systems, advancements in insulin administration technology, bionic technology advancements.

The forecast of 8.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microfluidic chips and Bluetooth-enabled dose trackers, sourced from key regions such as Singapore and Canada, which could lead to reduced diabetes management options and increased costs for smart insulin technology.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the Centers for Disease Control and Prevention, a U.S.-based government agency, as of December 2022, the number of young people under 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Additionally, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens; Insulin Pumps; External Or Tethered Pumps; Patch Pumps
  • 2) By Disease Indication: Type 1; Type 2
  • 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
  • Subsegments:
  • 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
  • 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
  • 3) By Pen Needles: Short Pen Needles; Long Pen Needles
  • 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
  • 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
  • 6) By Insulin Pumps: Traditional Insulin Pumps; Smart Insulin Pumps
  • 7) By External Or Tethered Pumps: Traditional External Insulin Pumps; Wireless Tethered Pumps
  • 8) By Patch Pumps: Patch Insulin Pumps; Integrated Patch Pumps
  • Companies Mentioned: Sanofi SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Eli Lilly and Company; Novo Nordisk A/S; Becton, Dickinson and Company; EOFlow Co. Ltd.; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Xeris Pharmaceuticals Inc.; Beta Bionics Inc.; Zealand Pharma AS; Bigfoot Biomedical Inc.; Emperra GmbH; Animas Corporation; Debiotech SA; CeQur Corporation; Aerami Therapeutics Inc.; Alshifa Medical Group; AMF Medical SA; Andain Inc.; Avecho Biotechnology Ltd.; Apex Medical Devices
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Insulin Delivery Devices Market Characteristics

3. Insulin Delivery Devices Market Trends And Strategies

4. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Insulin Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Insulin Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Insulin Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Insulin Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Insulin Delivery Devices Total Addressable Market (TAM)

6. Insulin Delivery Devices Market Segmentation

  • 6.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Syringes
  • Insulin Jet Injectors
  • Pen Needles
  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Insulin Pumps
  • External Or Tethered Pumps
  • Patch Pumps
  • 6.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1
  • Type 2
  • 6.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Diabetes Clinics Or Centres
  • 6.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Insulin Syringes
  • Insulin Syringes With Fixed Or Adjustable Needle Length
  • 6.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Needle-Free Insulin Jet Injectors
  • High-Pressure Insulin Jet Injectors
  • 6.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short Pen Needles
  • Long Pen Needles
  • 6.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reusable Pens With Replaceable Cartridges
  • Refillable Insulin Pens
  • 6.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Disposable Insulin Pens
  • Pre-Filled Disposable Insulin Pens
  • 6.9. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Insulin Pumps
  • Smart Insulin Pumps
  • 6.10. Global Insulin Delivery Devices Market, Sub-Segmentation Of External Or Tethered Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional External Insulin Pumps
  • Wireless Tethered Pumps
  • 6.11. Global Insulin Delivery Devices Market, Sub-Segmentation Of Patch Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch Insulin Pumps
  • Integrated Patch Pumps

7. Insulin Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Insulin Delivery Devices Market

  • 8.1. Asia-Pacific Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Insulin Delivery Devices Market

  • 9.1. China Insulin Delivery Devices Market Overview
  • 9.2. China Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Insulin Delivery Devices Market

  • 10.1. India Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Insulin Delivery Devices Market

  • 11.1. Japan Insulin Delivery Devices Market Overview
  • 11.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Insulin Delivery Devices Market

  • 12.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Insulin Delivery Devices Market

  • 13.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Insulin Delivery Devices Market

  • 14.1. South Korea Insulin Delivery Devices Market Overview
  • 14.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Insulin Delivery Devices Market

  • 15.1. Western Europe Insulin Delivery Devices Market Overview
  • 15.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Insulin Delivery Devices Market

  • 16.1. UK Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Insulin Delivery Devices Market

  • 17.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Insulin Delivery Devices Market

  • 18.1. France Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Insulin Delivery Devices Market

  • 19.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Insulin Delivery Devices Market

  • 20.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Insulin Delivery Devices Market

  • 21.1. Eastern Europe Insulin Delivery Devices Market Overview
  • 21.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Insulin Delivery Devices Market

  • 22.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Insulin Delivery Devices Market

  • 23.1. North America Insulin Delivery Devices Market Overview
  • 23.2. North America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Insulin Delivery Devices Market

  • 24.1. USA Insulin Delivery Devices Market Overview
  • 24.2. USA Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Insulin Delivery Devices Market

  • 25.1. Canada Insulin Delivery Devices Market Overview
  • 25.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Insulin Delivery Devices Market

  • 26.1. South America Insulin Delivery Devices Market Overview
  • 26.2. South America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Insulin Delivery Devices Market

  • 27.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Insulin Delivery Devices Market

  • 28.1. Middle East Insulin Delivery Devices Market Overview
  • 28.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Insulin Delivery Devices Market

  • 29.1. Africa Insulin Delivery Devices Market Overview
  • 29.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Insulin Delivery Devices Market Competitive Landscape
  • 30.2. Insulin Delivery Devices Market Company Profiles
    • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Insulin Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk A/S
  • 31.2. Becton, Dickinson and Company
  • 31.3. EOFlow Co. Ltd.
  • 31.4. Insulet Corporation
  • 31.5. Tandem Diabetes Care Inc.
  • 31.6. Ypsomed Holding AG
  • 31.7. Xeris Pharmaceuticals Inc.
  • 31.8. Beta Bionics Inc.
  • 31.9. Zealand Pharma AS
  • 31.10. Bigfoot Biomedical Inc.
  • 31.11. Emperra GmbH
  • 31.12. Animas Corporation
  • 31.13. Debiotech SA
  • 31.14. CeQur Corporation
  • 31.15. Aerami Therapeutics Inc.

32. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

34. Recent Developments In The Insulin Delivery Devices Market

35. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Insulin Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Insulin Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Insulin Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer